These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23021007)

  • 1. Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis.
    Catanoso MG; Spaggiari L; Magnani L; Pipitone N; Versari A; Boiardi L; Pazzola G; Pattacini P; Salvarani C
    Clin Exp Rheumatol; 2012; 30(5):776-8. PubMed ID: 23021007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Accorsi Buttini E; Maritati F; Vaglio A
    Eur Urol; 2018 Jan; 73(1):145-146. PubMed ID: 29033102
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.
    Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Hanami K; Tanaka Y
    Mod Rheumatol; 2011 Apr; 21(2):184-91. PubMed ID: 21052764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
    Yoshida S; Takeuchi T; Yoshikawa A; Ozaki T; Fujiki Y; Hata K; Makino S; Hanafusa T
    Mod Rheumatol; 2012 Sep; 22(5):791-5. PubMed ID: 22245952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
    Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography.
    Vaglio A; Greco P; Versari A; Filice A; Cobelli R; Manenti L; Salvarani C; Buzio C
    Clin Exp Rheumatol; 2005; 23(2):231-4. PubMed ID: 15895895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
    Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
    J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earlobe sarcoidosis.
    Vorselaars AD; Keijsers RG; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2012 Mar; 29(1):55-7. PubMed ID: 23311125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis.
    Pipitone N; Versari A; Vaglio A; Salvarani C
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S72-8. PubMed ID: 21418782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined immunosuppressive therapy including a TNF-alpha blocker induces remission in a difficult to treat patient with Takayasu arteriitis and coronary involvement.
    Mahlmann A; Pfluecke C; Ouda A; Simonis G; Weiss N; Kappert U
    Vasa; 2012 Nov; 41(6):451-7. PubMed ID: 23129041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
    Jansen I; Hendriksz TR; Han SH; Huiskes AW; van Bommel EF
    Eur J Intern Med; 2010 Jun; 21(3):216-21. PubMed ID: 20493425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful therapy of retroperitoneal fibrosis due to IgG4-related disease with rituximab, cyclophosphamide and glucocorticoids followed by maintenance therapy wit ritutixmab].
    Adam Z; Čermák A; Petrášová H; Řehák Z; Koukalová R; Fojtík Z; Pour L; Boichuk I; Krejčí M; Král Z; Benda P
    Vnitr Lek; 2023; 69(E-3):4-15. PubMed ID: 37468330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases.
    Young PM; Peterson JJ; Calamia KT
    Ann Nucl Med; 2008 Jan; 22(1):87-92. PubMed ID: 18250993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.
    Tanaka F; Kawakami A; Iwanaga N; Tamai M; Izumi Y; Aratake K; Arima K; Kamachi M; Nakamura H; Huang M; Ida H; Origuchi T; Eguchi K
    Intern Med; 2006; 45(5):313-6. PubMed ID: 16596001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fluorine-18-deoxyglucose positron emission tomography/computed tomography and contrast-enhanced ultrasound in a patient with chronic periaortitis.
    Steubl D; Thürmel K; Moog P; Essler M; Heemann U; Stock KF
    Vasa; 2013 Sep; 42(5):370-4. PubMed ID: 23989073
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiopathic Retroperitoneal Fibrosis: Long-term Risk and Predictors of Relapse.
    Raffiotta F; da Silva Escoli R; Quaglini S; Rognoni C; Sacchi L; Binda V; Messa P; Moroni G
    Am J Kidney Dis; 2019 Dec; 74(6):742-750. PubMed ID: 31204195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension.
    Bargagli E; Galeazzi M; Bellisai F; Volterrani L; Rottoli P
    Respiration; 2008; 75(3):346-9. PubMed ID: 16369127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.
    Salvarani C; Magnani L; Catanoso MG; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S90-3. PubMed ID: 22410150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-fluorodeoxyglucose positron emission tomography in a case of retroperitoneal fibrosis.
    Sakamoto A; Okamoto K; Ishizaka N; Tejima K; Hirata Y; Nagai R
    Int Heart J; 2006 Jul; 47(4):645-50. PubMed ID: 16960419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial.
    Vaglio A; Palmisano A; Alberici F; Maggiore U; Ferretti S; Cobelli R; Ferrozzi F; Corradi D; Salvarani C; Buzio C
    Lancet; 2011 Jul; 378(9788):338-46. PubMed ID: 21733570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.